Regular (R) insulin is a short-acting, injectable insulin used for the management of diabetes. It is typically taken before meals to prevent glucose from rising after a person eats. Regular insulin is ...

A 52-week, randomized, open-label, parallel-group, phase 3a trial with real-world elements was conducted at 176 sites in seven countries. A total of 1085 insulin-naive patients with type 2 diabetes ...

A patient-facing voice-based conversational artificial intelligence (VBAI) application that provided autonomous basal insulin titration improved time to optimal insulin dosing, insulin adherence, and ...